Latest News about Pharmaceuticals
Recent news which mentions Pharmaceuticals
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
January 17, 2024
From CNBC.com News
Top pharma CEO says preparedness for a new pandemic has not improved
January 16, 2024
From CNBC.com News
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
January 14, 2024
From CNBC.com News
From CNBC.com News
From Business Journals
Atea Pharmaceuticals' Hepatitis C Virus Candidate Shows Efficacy
January 09, 2024
From Benzinga
Short Seller's Bombshell Report Rattles Grifols: Stock Chart Points To Potential Further Decline
January 09, 2024
From Benzinga
Bristol-Myers CEO talks new acquisitions: 'We are writing the next chapter of this company'
January 08, 2024
From CNBC.com News
Walgreens CEO says company is using its stores and brand to boost health-care business
January 08, 2024
Tickers
CEO
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
January 08, 2024
From CNBC.com News
Moderna Covid vaccine sales plunge by two-thirds in 2023, but meet company's $6 billion forecast
January 08, 2024
From CNBC.com News
Eli Lilly's direct drug sales may not upend the industry alone – but others could follow suit
January 05, 2024
From CNBC.com News
Healthcare Champions Kick Off 2024
January 05, 2024
From Benzinga
Florida wins first FDA approval to import cheaper drugs from Canada
January 05, 2024
From CNBC.com News
QuantumScape, Peloton, Eli Lilly, Walgreens, Tesla: Why These 5 Stocks Are On Investors' Radars Today
January 04, 2024
From Benzinga
Eli Lilly Launches Website To Help Patients With Home Delivery Options For Weight Loss Medicines
January 04, 2024
From Benzinga
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.